SIRT1 and metabolic dysfunction-associated steatohepatitis: Stacchiotti et al. [14] found that the beneficial effect of melatonin on NAFLD/nonalcoholic steatohepatitis (NASH) in mice was associated with reduced miR‐34a‐5p levels in the presence of Sirt1.